Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Schizophrenia

  Free Subscription


Articles published in Pharmacopsychiatry

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    May 2008
  1. GODER R , Fritzer G, Gottwald B, Lippmann B, et al
    Effects of olanzapine on slow wave sleep, sleep spindles and sleep-related memory consolidation in schizophrenia.
    Pharmacopsychiatry. 2008;41:92-9.
    PubMed     Related articles    Abstract available


    January 2008
  2. ASSION HJ , Reinbold H, Lemanski S, Basilowski M, et al
    Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Pharmacopsychiatry. 2008;41:24-8.
    PubMed     Related articles    Abstract available


    December 2007
  3. LOH M , Rolls ET, Deco G
    Statistical fluctuations in attractor networks related to schizophrenia.
    Pharmacopsychiatry. 2007;40 Suppl 1:S78-84.
    PubMed     Related articles    Abstract available


  4. VOGELS TP , Abbott LF
    Gating deficits in model networks: a path to schizophrenia?
    Pharmacopsychiatry. 2007;40 Suppl 1:S73-7.
    PubMed     Related articles    Abstract available


  5. MEISENZAHL EM , Scheuerecker J, Schmitt GJ, Moller HJ, et al
    Dopamine, prefrontal cortex and working memory functioning in schizophrenia.
    Pharmacopsychiatry. 2007;40 Suppl 1:S62-72.
    PubMed     Related articles    Abstract available


  6. HAENSCHEL C , Uhlhaas PJ, Singer W
    Synchronous oscillatory activity and working memory in schizophrenia.
    Pharmacopsychiatry. 2007;40 Suppl 1:S54-61.
    PubMed     Related articles    Abstract available


  7. WINTERER G
    Prefrontal dopamine signaling in schizophrenia - the corticocentric model.
    Pharmacopsychiatry. 2007;40 Suppl 1:S45-53.
    PubMed     Related articles    Abstract available


  8. GALLINAT J , Obermayer K, Heinz A
    Systems neurobiology of the dysfunctional brain: schizophrenia.
    Pharmacopsychiatry. 2007;40 Suppl 1:S40-4.
    PubMed     Related articles    Abstract available


  9. KOCH M
    On the effects of partial agonists of dopamine receptors for the treatment of schizophrenia.
    Pharmacopsychiatry. 2007;40 Suppl 1:S34-9.
    PubMed     Related articles    Abstract available


  10. TRETTER F , Albus M
    Computational neuropsychiatry of working memory disorders in schizophrenia: the network connectivity in prefrontal cortex - data and models.
    Pharmacopsychiatry. 2007;40 Suppl 1:S2-S16.
    PubMed     Related articles    Abstract available


  11. DI PIETRO NC , Seamans JK
    Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.
    Pharmacopsychiatry. 2007;40 Suppl 1:S27-33.
    PubMed     Related articles    Abstract available


    November 2007
  12. GALLHOFER B , Jaanson P, Mittoux A, Tanghoj P, et al
    Course of Recovery of Cognitive Impairment in Patients with Schizophrenia: A Randomised Double-blind Study Comparing Sertindole and Haloperidol.
    Pharmacopsychiatry. 2007;40:275-86.
    PubMed     Related articles    Abstract available


  13. XIANG YT , Weng YZ, Leung CM, Tang WK, et al
    Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of chinese schizophrenia patients.
    Pharmacopsychiatry. 2007;40:269-74.
    PubMed     Related articles    Abstract available


  14. DE HAAN L , van Amelsvoort T, Dingemans P, Linszen D, et al
    Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.
    Pharmacopsychiatry. 2007;40:264-8.
    PubMed     Related articles    Abstract available


  15. MARINIS TD , Saleem PT, Glue P, Arnoldussen WJ, et al
    Switching to Long-Acting Injectable Risperidone is Beneficial with Regard to Clinical Outcomes, Regardless of Previous Conventional Medication in Patients with Schizophrenia.
    Pharmacopsychiatry. 2007;40:257-63.
    PubMed     Related articles    Abstract available


  16. OULIS P , Koulouris GC, Konstantakopoulos G, Masdrakis VG, et al
    Marked elevation of creatine kinase with sertindole: a case report.
    Pharmacopsychiatry. 2007;40:295-6.
    PubMed     Related articles   


    September 2007
  17. KIRSCH P , Ronshausen S, Mier D, Gallhofer B, et al
    The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients.
    Pharmacopsychiatry. 2007;40:196-8.
    PubMed     Related articles    Abstract available


  18. PLESNICAR BK , Lasic JK, Plesnicar A
    Quetiapine and elevated creatine phosphokinase (CK).
    Pharmacopsychiatry. 2007;40:203-4.
    PubMed     Related articles   


  19. ZINK M , Englisch S, Knopf U, Kuwilsky A, et al
    Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Pharmacopsychiatry. 2007;40:202-3.
    PubMed     Related articles   


  20. WESTHEIDE J , Helmstaedter C, Elger C, Cooper-Mahkorn D, et al
    Sexuality in male psychiatric inpatients. a descriptive comparison of psychiatric patients, patients with epilepsy and healthy volunteers.
    Pharmacopsychiatry. 2007;40:183-90.
    PubMed     Related articles    Abstract available


    July 2007
  21. NEUHAUS AH , Luborzewski A, Opgen-Rhein C, Jockers-Scherubl MC, et al
    Electroconvulsive monotherapy in confusion psychosis: a potential standard regimen?
    Pharmacopsychiatry. 2007;40:170-1.
    PubMed     Related articles    Abstract available


  22. BALDACARA L , de Castro Ferrari MC, Monteiro BF, Uchida RR, et al
    Hypomania Induced by Atypical Antipsychotics among Schizophrenic Patients: Report of Three Cases.
    Pharmacopsychiatry. 2007;40:169-70.
    PubMed     Related articles    Abstract available


  23. DROZDZ W , Borkowska A, Wilkosc M, Halota W, et al
    Chronic Paranoid Psychosis and Dementia Following Interferon-alpha Treatment of Hepatitis C: A Case Report.
    Pharmacopsychiatry. 2007;40:146-8.
    PubMed     Related articles    Abstract available


  24. MOLINA V , Reig S, Sanz J, Palomo T, et al
    Changes in cortical volume with olanzapine in chronic schizophrenia.
    Pharmacopsychiatry. 2007;40:135-9.
    PubMed     Related articles    Abstract available


  25. MOLINA V , Sanz J, Sarramea F, Palomo T, et al
    Marked hypofrontality in clozapine-responsive patients.
    Pharmacopsychiatry. 2007;40:157-62.
    PubMed     Related articles    Abstract available


  26. SCHAEFER M , Leopold K, Hinzpeter A, Heinz A, et al
    Memantine-associated reversal of clozapine-induced weight gain.
    Pharmacopsychiatry. 2007;40:149-51.
    PubMed     Related articles    Abstract available


  27. WESTHEIDE J , Cohen S, Bender S, Cooper-Mahkorn D, et al
    Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication.
    Pharmacopsychiatry. 2007;40:140-5.
    PubMed     Related articles    Abstract available


    May 2007
  28. STOLK P , Souverein PC, Leufkens HG, Weil JG, et al
    The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration. A Nested Case-Control Study.
    Pharmacopsychiatry. 2007;40:111-5.
    PubMed     Related articles    Abstract available


  29. RASHID J , Wang R, Ramer SL
    Atypical antipsychotics and seborrheic dermatitis: three case reports.
    Pharmacopsychiatry. 2007;40:103-6.
    PubMed     Related articles    Abstract available


  30. MAURI MC , Colasanti A, Rossattini M, Volonteri LS, et al
    Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.
    Pharmacopsychiatry. 2007;40:89-92.
    PubMed     Related articles    Abstract available


    March 2007
  31. HUNG GC , Chen YY
    Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient.
    Pharmacopsychiatry. 2007;40:83-4.
    PubMed     Related articles   


  32. XIANG YT , Weng YZ, Leung CM, Tang WK, et al
    Clinical and social determinants of antipsychotic polypharmacy for chinese patients with schizophrenia.
    Pharmacopsychiatry. 2007;40:47-52.
    PubMed     Related articles    Abstract available


  33. GERLACH M , Hunnerkopf R, Rothenhofer S, Libal G, et al
    Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.
    Pharmacopsychiatry. 2007;40:72-6.
    PubMed     Related articles    Abstract available


    January 2007
  34. DOMULA M , Schulze D, Felber W, Gallinat J, et al
    Cat eye syndrome associated with schizophrenia.
    Pharmacopsychiatry. 2007;40:38-9.
    PubMed     Related articles   


  35. YOSHIMURA R , Shinkai K, Ueda N, Nakamura J, et al
    Valproic Acid improves Psychotic Agitation without Influencing Plasma Risperidone Levels in Schizophrenic Patients.
    Pharmacopsychiatry. 2007;40:9-13.
    PubMed     Related articles    Abstract available


  36. HOFER A , Rettenbacher MA, Edlinger M, Huber R, et al
    Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.
    Pharmacopsychiatry. 2007;40:1-8.
    PubMed     Related articles    Abstract available


  37. HABERFELLNER EM
    Priapism with sertraline-risperidone combination.
    Pharmacopsychiatry. 2007;40:44-5.
    PubMed     Related articles   


  38. TRABER R , Schneiter R, Modestin J
    A case of aripiprazole-induced mania.
    Pharmacopsychiatry. 2007;40:37-8.
    PubMed     Related articles   


    November 2006
  39. WEIS S , Karagulle D, Kornhuber J, Bayerlein K, et al
    Cotrimoxazole-induced Psychosis: A Case Report and Review of Literature.
    Pharmacopsychiatry. 2006;39:236-7.
    PubMed     Related articles    Abstract available


  40. NORMANN C , Schmauss M, Bakri N, Gerwe M, et al
    Initial Treatment of Severe Acute Psychosis with Fast Orally Disintegrating Risperidone Tablets.
    Pharmacopsychiatry. 2006;39:209-212.
    PubMed     Related articles    Abstract available


  41. DEUSCHLE M , Mase E, Zink M
    Dyskinesia during treatment with duloxetine.
    Pharmacopsychiatry. 2006;39:237-8.
    PubMed     Related articles   


  42. DABBERT D , Heinze M
    Follow-up of a pregnancy with risperidone microspheres.
    Pharmacopsychiatry. 2006;39:235.
    PubMed     Related articles    Abstract available


  43. DEMLING JH , Huang ML, Remmerie B, Mannaert E, et al
    Pharmacokinetics and safety of combination therapy with lithium and risperidone.
    Pharmacopsychiatry. 2006;39:230-1.
    PubMed     Related articles   


    July 2006
  44. BAI YM , Chen TT, Wu B, Hung CH, et al
    A comparative efficacy and safety study of long-acting risperidone injection and risperidone oral tablets among hospitalized patients: 12-week randomized, single-blind study.
    Pharmacopsychiatry. 2006;39:135-41.
    PubMed     Related articles    Abstract available


  45. TENYI T , Voros V
    Successful switch to olanzapine after rhabdomyolysis caused by water intoxication and clozapine use.
    Pharmacopsychiatry. 2006;39:157-8.
    PubMed     Related articles    Abstract available


    May 2006
  46. PASCUAL JC , Madre M, Soler J, Barrachina J, et al
    Injectable atypical antipsychotics for agitation in borderline personality disorder.
    Pharmacopsychiatry. 2006;39:117-8.
    PubMed     Related articles    Abstract available


  47. ZINK M , Knopf U, Mase E, Kuwilsky A, et al
    Duloxetine treatment of major depressive episodes in the course of psychotic disorders.
    Pharmacopsychiatry. 2006;39:109-11.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: